Akron’s CryoSolve® product is manufactured following all relevant cGMP guidelines for ancillary materials. The formulation contains sterile, filtered DMSO (Dimethyl Sulfoxide, USP/EP) and Dextran-40 (USP/EP/JP). Its packaging design (single-use syringe) supports the quality standards for cord blood processing in a closed system. Our CryoSolve® product maximizes the rate of cord blood processing for storage, leading to a notable impact on time and volume.
Aseptic filling is performed after sterile filtration with Endotoxin, Mycoplasma, and Sterility testing performed per USP on the final product. Our cryopreservation media is packaged in syringes and available in 7 mL and 8 mL aliquot sizes. Akron’s cGMP-compliant CryoSolve® product is intended for the cryopreservation of hematopoietic cells in cord blood.
For research use or further manufacturing use in ex vivo cell therapy applications. This product is not intended for direct in vivo use or for direct clinical use as a drug, therapeutic, biologic, or medical device.
• Appearance
• pH
• Osmolality
• Identification
• Purity
• Cytotoxicity
• Mycoplasma
• Bacterial Endotoxins
• Sterility
Syringe Kit (7 mL x 25) Cat # AK8217-2507
Syringe Kit (8 mL x 25) Cat # AK8217-2508